UN health agency updates guidelines on COVID-19 therapeutics

The World Health Organization is helping countries boost testing capacity for SARS-CoV-2, the virus that causes COVID-19 (Photo via WHO)

(United Nations News) The World Health Organization (WHO), for the first time, included an oral antiviral drug in its COVID-19 treatment guidance.

The updated “living guidelines” on related therapeutics now include conditional recommendations on the medication, molnupiravir, the UN agency announced on Thursday.

Citing concerns and data gaps, WHO advanced that molnupiravir should be provided “only to non-severe COVID-19 patients with the highest risk of hospitalisation,” WHO alerted.

Those are typically people who have not received a COVID-19 vaccination, older people, people with immunodeficiencies and those living with chronic diseases.

WHO also recommended that children, and pregnant and breastfeeding women should not be given the drug, adding that people who take molnupiravir should have a contraceptive plan.

Read more at: United Nations News

Comments are closed.

%d bloggers like this: